Capabilities
Our manufacturing capabilities now include multiple automated lines
dedicated to producing glass ampules, vials, and ophthalmic bottles.
Our manufacturing facility in India has been compliant with the
standards set by the United States Food and Drug Administration
(USFDA) since 2013.
Looking towards the future, we are actively expanding our
infrastructure. This includes the construction of two new
manufacturing buildings in Bengaluru and one in New Jersey. These
additions will enable us to venture into new dosage forms, such as
inhalation, topicals, and lyophilization.s
Our manufacturing capabilities now include multiple automated lines
dedicated to producing glass ampules, vials, and ophthalmic bottles.
Our manufacturing facility in India has been compliant with the
standards set by the United States Food and Drug Administration
(USFDA) since 2013.
Looking towards the future, we are actively expanding our
infrastructure. This includes the construction of two new
manufacturing buildings in Bengaluru and one in New Jersey. These
additions will enable us to venture into new dosage forms, such as
inhalation, topicals, and lyophilization.s
Our manufacturing capabilities now include multiple automated lines
dedicated to producing glass ampules, vials, and ophthalmic bottles.
Our manufacturing facility in India has been compliant with the
standards set by the United States Food and Drug Administration
(USFDA) since 2013.
Looking towards the future, we are actively expanding our
infrastructure. This includes the construction of two new
manufacturing buildings in Bengaluru and one in New Jersey. These
additions will enable us to venture into new dosage forms, such as
inhalation, topicals, and lyophilization.s